StockWatch
·
Pharmaceuticals
Quarterly Result24 Jul 2026, 02:52 pm

Laurus Labs declares Q1 FY27 Unaudited Financial Results

AI Summary

Laurus Labs Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results on July 24, 2026. The financial statements, along with the limited review reports from Deloitte Haskins & Sells LLP, are available on the company's website and stock exchange portals. The board meeting commenced at 2:00 PM IST and concluded at 2:42 PM IST.

Key Highlights

  • Laurus Labs declared unaudited financial results for Q1 FY27.
  • Results are available on company and stock exchange websites.
  • Limited review reports from statutory auditors are included.
  • Board meeting to approve results was held on July 24, 2026.